Key facts
- Shangxin Capital is a other based in Shanghai, China with 1 tracked portfolio company.
- Notable positions include Trinomab(Zhuhai).
About Shangxin Capital
Shangxin Capital is a venture capital firm headquartered in Shanghai, China. Established in 2014, the firm seeks to make investments into life science and medical technology companies. The assets of the firm are managed and governed by an executive management team.
Free account
See the whole book
- ·Watchlist + alerts for Shangxin Capital's activity
Create free account
No card required
Portfolio, priced
1 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Trinomab(Zhuhai) | — | $533.7M | — |
Frequently asked
- What companies does Shangxin Capital invest in?
- Shangxin Capital has 1 recorded portfolio companies, including Trinomab(Zhuhai).
- What is Shangxin Capital's AUM?
- Shangxin Capital manages approximately $1K in assets.